Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus

Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus

More than half of the patients with heart failure have preserved ejection fraction (HFpEF), however evidence shows a mortality rate comparable to those with reduced ejection fraction. The aim of this study was to evaluate whether FGF21, galectin-3 and copeptin can be used as biomarkers to identify H...

Full description

Bibliographic Details
Main Authors: Raluca D. Ianoș, Călin Pop, Mihaela Iancu, Rodica Rahaian, Angela Cozma, Lucia M. Procopciuc
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Diagnostics
Subjects:
biomarkers
heart failure
preserved ejection fraction
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/2075-4418/11/9/1577

Similar Items

Similar Items